Overview

Efficacy and Safety of Rupatadine 10 and 20 Mg in Chronic Idiopathic Urticaria

Status:
Terminated
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
ยท To evaluate the efficacy of rupatadine 10 and 20 mg for the treatment of CIU symptoms over four-week treatment period in comparison with placebo.
Phase:
Phase 3
Details
Lead Sponsor:
J. Uriach and Company
Treatments:
Cyproheptadine